Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes

Saadet Türkseven, Adam Kruger, Christopher J. Mingone, +6

American Journal of Physiology-Heart and Circulatory Physiology

Experimental DiabetesRedox BiologyAntioxidant MechanismOxidative StressSuperoxide Dismutase +15

D-4F Induces Heme Oxygenase-1 and Extracellular Superoxide Dismutase, Decreases Endothelial Cell Sloughing, and Improves Vascular Reactivity in Rat Model of Diabetes

Adam Kruger, Stephen J. Peterson, Saadet Türkseven, +5

Circulation

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

Stephen J. Peterson, George I. Drummond, Dong Hyun Kim, +4

Journal of Lipid Research

ObesityNutritionMetabolic SyndromeInsulin SensitivityEnergy Homeostasis +12

Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: Correlation with cardiovascular risk

Adam Kruger, Julian M. Stewart, Rachna Sahityani, +6

Kidney International

HypertensionUrologyRenal FunctionCardiovascular DiseaseMedicine +10

Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects

Adam Kruger, Stephen J. Peterson, Michal L. Schwartzman, +8

Journal of Pharmacology and Experimental Therapeutics

Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes

Nader G. Abraham, Rita Rezzani, Luigi Fabrizio Rodella, +5

American Journal of Physiology-Heart and Circulatory Physiology

Experimental DiabetesRedox BiologyOxidative StressInflammationMetabolic Syndrome +16

Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats

Stephen J. Peterson, Daniel Husney, Adam Kruger, +9

Journal of Pharmacology and Experimental Therapeutics

Effect of Beta Blockers, Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers, and Statins on Mortality in Patients With Implantable Cardioverter-Defibrillators

Hoang M. Lai, Wilbert S. Aronow, Adam Kruger, +5

The American Journal of Cardiology

HypertensionCardiovascular DiseaseAngiotensin Receptor BlockersMyocardial InfarctionCardiovascular Pharmacology +9

Usefulness of Clopidogrel to Protect Against Diabetes-Induced Vascular Damage

John A. McClung, Adam Kruger, Ambra Ferraris, +4

The American Journal of Cardiology

Diabetes ManagementCardiovascular DiseaseMedicineDiabetesDiabetes Mellitus +2

Prevalence of Complications During Implantation and During 38-Month Follow-up of 1060 Consecutive Patients With Implantable Cardioverter-Defibrillators

Fausan S. Tsai, Wilbert S. Aronow, Srikala Devabhaktuni, +6

American Journal of Therapeutics

Heart FailureCardiac AnaesthesiaDevice TherapySurgeryConsecutive Patients +16